Rare diseases
Investigational molecules
Locations
Stenbackinkatu 9, 00290 Helsinki, Finland
HUS-yhtymae supports clinical research in breast cancer, colorectal cancer, rectal cancer, gastric cancer, pancreatic cancer, head and neck carcinoma, and broader advanced cancer care, with additional interest in myeloma multiplex and Monoclonal Gammopathy of Renal Significance.
Its oncology portfolio also includes treatment-related thromboprophylaxis, perioperative support, and evaluation of antineoplastic therapies across solid tumours and plasma cell disorders.
HUS-yhtymae runs clinical trials in conditions such as Neoplasm malignant, Embolism venous, Breast cancer, Laryngitis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FinlandFinlandFinlandFinlandFinlandFinlandFinlandFinlandFinlandFinlandFinlandFinlandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
